+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Grifols, S.A. - logo

Grifols is a leading producer of plasma-derived protein therapies for patients who have rare, genetic diseases and life-threatening infections. They are currently the largest supplier of source plasma for plasma therapy production in the world. They have built a network of 147 plasma donation centers throughout the United States and their annual plasma collection exceeds 6.5 million liters. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

Myasthenia Gravis Drugs - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Drugs - Global Strategic Business Report

  • Report
  • April 2024
  • 182 Pages
  • Global
From
Global Rare Hemophilia Factors Market 2022-2026 - Product Thumbnail Image

Global Rare Hemophilia Factors Market 2022-2026

  • Report
  • June 2022
  • 120 Pages
  • Global
From
Hemophilia Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 143 Pages
  • Global
From
Loading Indicator